BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37140173)

  • 1. High-dose bevacizumab for radiation-induced brain necrosis: a case report.
    Panagiotou E; Charpidou A; Fyta E; Nikolaidou V; Stournara L; Syrigos A; Gkiozos I
    CNS Oncol; 2023 Sep; 12(3):CNS98. PubMed ID: 37140173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment.
    Furuuchi K; Nishiyama A; Yoshioka H; Yokoyama T; Ishida T
    Respir Investig; 2017 Mar; 55(2):184-187. PubMed ID: 28274537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.
    Moore A; Yust-Katz S; Icht O; Eliyahou R; Gordon N; Cohen AY; Goldstein IM; Peled N; Seigal T; Amiel A; Dudnik E
    J Neurol Sci; 2021 Aug; 427():117556. PubMed ID: 34186494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review.
    Rahmathulla G; Recinos PF; Valerio JE; Chao S; Barnett GH
    Stereotact Funct Neurosurg; 2012; 90(3):192-200. PubMed ID: 22678505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
    Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
    Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
    Furuse M; Kawabata S; Kuroiwa T; Miyatake S
    J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
    Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
    J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
    Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
    Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
    Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
    Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
    Ma Y; Zheng C; Feng Y; Xu Q
    J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
    J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
    Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
    Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC.
    Li L; Feng M; Xu P; Wu YL; Yin J; Huang Y; Tan MY; Jinyi L
    Int J Neurosci; 2023 Mar; 133(3):334-341. PubMed ID: 33843421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
    Chung C; Bryant A; Brown PD
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011492. PubMed ID: 29987845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
    J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
    Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
    Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
    Bodensohn R; Hadi I; Fleischmann DF; Corradini S; Thon N; Rauch J; Belka C; Niyazi M
    Strahlenther Onkol; 2020 Jan; 196(1):70-76. PubMed ID: 31586230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety and Efficacy of Bevacizumab for Radiosurgery - Induced Steroid - Resistant Brain Edema; Not the Last Part in the Ship of Theseus.
    Tripathi M; Ahuja CK; Mukherjee KK; Kumar N; Dhandapani S; Dutta P; Kaur R; Rekhapalli R; Batish A; Gurnani J; Kamboj P; Agrahari A; Kataria K
    Neurol India; 2019; 67(5):1292-1302. PubMed ID: 31744962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of repeated low-dose bevacizumab treatment with long-dosing interval for radiation-induced brain necrosis: A case report.
    Meng X; Zhao R; Wu S; Shen G; Ding L; Sun B; Wang J
    Cancer Biol Ther; 2017 Jan; 18(1):63-66. PubMed ID: 28152324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.